280
Participants
Start Date
Not specified
Study Completion Date
May 31, 1998
Lamivudine
Stavudine
Zidovudine
Didanosine
NY Univ. HIV/AIDS CRS, New York
Cornell University A2201, New York
SUNY - Buffalo, Erie County Medical Ctr., Buffalo
Univ. of Rochester ACTG CRS, Rochester
Hosp. of the Univ. of Pennsylvania CRS, Philadelphia
Johns Hopkins Adult AIDS CRS, Baltimore
Regional Center for Infectious Disease, Wendover Medical Center CRS, Greensboro
Unc Aids Crs, Chapel Hill
Carolinas HealthCare System, Carolinas Med. Ctr., Charlotte
Emory Univ. Hemophilia Program Office, Atlanta
Univ. of Cincinnati CRS, Cincinnati
Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis
Northwestern University CRS, Chicago
Cook County Hosp. CORE Ctr., Chicago
Rush Univ. Med. Ctr. ACTG CRS, Chicago
USC CRS, Los Angeles
UCLA CARE Center CRS, Los Angeles
Harbor-UCLA Med. Ctr. CRS, Torrance
Ucsd, Avrc Crs, San Diego
Stanford CRS, Palo Alto
University of Washington AIDS CRS, Seattle
Alabama Therapeutics CRS, Birmingham
Ucsf Aids Crs, San Francisco
Santa Clara Valley Med. Ctr., San Jose
San Mateo County AIDS Program, San Mateo
University of Colorado Hospital CRS, Aurora
Univ. of Miami AIDS CRS, Miami
Tulane Hemophilia Treatment Ctr., New Orleans
Beth Israel Deaconess - East Campus A0102 CRS, Boston
Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston
University of Minnesota, ACTU, Minneapolis
St. Louis ConnectCare, Infectious Diseases Clinic, St Louis
Washington U CRS, St Louis
Univ. of Nebraska Med. Ctr., Durham Outpatient Ctr., Omaha
Case CRS, Cleveland
The Ohio State Univ. AIDS CRS, Columbus
Puerto Rico-AIDS CRS, San Juan
Mbeya Med. Research Program, Mbeya Referral Hosp. CRS, Mbeya
Massachusetts General Hospital ACTG CRS, Boston
Bmc Actg Crs, Boston
National Institute of Allergy and Infectious Diseases (NIAID)
NIH